Literature DB >> 34312215

A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop.

Daniel D Von Hoff1, Gary M Clark2, Charles A Coltman, Mary L Disis3, S G Eckhardt4, Lee M Ellis5, Margaret Foti6, Elizabeth Garrett-Mayer7, Mithat Gönen8, Manuel Hidalgo9, Susan G Hilsenbeck10, John H Littlefield, Patricia M LoRusso11, H Kim Lyerly12, Neal J Meropol13,14, Jyoti D Patel15, Steven Piantadosi16, Dean A Post6, Meredith M Regan17, Yu Shyr18, Margaret A Tempero19, Joel E Tepper20, Jamie Von Roenn7, Louis M Weiner21, Donn C Young22, Nu V Vu23.   

Abstract

To address the need for clinical investigators in oncology, American Association for Cancer Research (AACR) and American Society for Clinical Oncology (ASCO) established the Methods in Clinical Cancer Research Workshop (MCCRW). The workshop's objectives were to: (i) provide training in the methods, design, and conduct of clinical trials; (ii) ensure that clinical trials met federal and international ethical guidelines; (iii) evaluate the effectiveness of the workshop; and (iv) create networking opportunities for young investigators with mentoring senior faculty. Educational methods included: (i) didactic lectures, (ii) Small Group Discussion Sessions, (iii) Protocol Development Groups, and (iv) one-on-one mentoring. Learning focused on the development of an Institutional Review Board (IRB)-ready protocol, which was submitted on the last day of the workshop. Evaluation methods included: (i) pre- and postworkshop tests, (ii) students' workshop evaluations, (iii) faculty's ratings of protocol development, (iv) students' productivity in clinical research after the workshop, and (v) an independent assessment of the workshop. From 1996 to 2014, 1,932 students from diverse backgrounds attended the workshop. There was a significant improvement in the students' level of knowledge from the pre- to the postworkshop exams (P < 0.001). Across the classes, student evaluations were very favorable. At the end of the workshop, faculty rated 92% to 100% of the students' protocols as ready for IRB submission. Intermediate and long-term follow-ups indicated that more than 92% of students were actively involved in patient-related research, and 66% had implemented five or more protocols. This NCI-sponsored MCCRW has had a major impact on the training of clinicians in their ability to design and implement clinical trials in cancer research. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2021        PMID: 34312215      PMCID: PMC8530870          DOI: 10.1158/1078-0432.CCR-21-1799

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  52 in total

1.  A shortage of oncologists? The American Society of Clinical Oncology workforce study.

Authors:  Gabriel N Hortobagyi
Journal:  J Clin Oncol       Date:  2007-03-14       Impact factor: 44.544

2.  Critical Aspects of a Sustainable Clinical Research Program in the Community-Based Oncology Practice.

Authors:  Jennifer L Ersek; Stephanie L Graff; Francis P Arena; Neelima Denduluri; Edward S Kim
Journal:  Am Soc Clin Oncol Educ Book       Date:  2019-05-17

Review 3.  Improving attribution of adverse events in oncology clinical trials.

Authors:  Goldy C George; Pedro C Barata; Alicyn Campbell; Alice Chen; Jorge E Cortes; David M Hyman; Lee Jones; Thomas Karagiannis; Sigrid Klaar; Jennifer G Le-Rademacher; Patricia LoRusso; Sumithra J Mandrekar; Diana M Merino; Lori M Minasian; Sandra A Mitchell; Sandra Montez; Daniel J O'Connor; Syril Pettit; Elaine Silk; Jeff A Sloan; Mark Stewart; Chris H Takimoto; Gilbert Y Wong; Timothy A Yap; Charles S Cleeland; David S Hong
Journal:  Cancer Treat Rev       Date:  2019-04-25       Impact factor: 12.111

Review 4.  Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward.

Authors:  Gary J Kelloff; Scott M Lippman; Andrew J Dannenberg; Caroline C Sigman; Homer L Pearce; Brian J Reid; Eva Szabo; V Craig Jordan; Margaret R Spitz; Gordon B Mills; Vali A Papadimitrakopoulou; Reuben Lotan; Bharat B Aggarwal; Robert S Bresalier; Jeri Kim; Banu Arun; Karen H Lu; Melanie E Thomas; Helen E Rhodes; Molly A Brewer; Michele Follen; Dong M Shin; Howard L Parnes; Jill M Siegfried; Alison A Evans; William J Blot; Wong-Ho Chow; Patricia L Blount; Carlo C Maley; Kenneth K Wang; Stephen Lam; J Jack Lee; Steven M Dubinett; Paul F Engstrom; Frank L Meyskens; Joyce O'Shaughnessy; Ernest T Hawk; Bernard Levin; William G Nelson; Waun Ki Hong
Journal:  Clin Cancer Res       Date:  2006-06-15       Impact factor: 12.531

Review 5.  Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development.

Authors:  Gary J Kelloff; John M Hoffman; Bruce Johnson; Howard I Scher; Barry A Siegel; Edward Y Cheng; Bruce D Cheson; Joyce O'shaughnessy; Kathryn Z Guyton; David A Mankoff; Lalitha Shankar; Steven M Larson; Caroline C Sigman; Richard L Schilsky; Daniel C Sullivan
Journal:  Clin Cancer Res       Date:  2005-04-15       Impact factor: 12.531

6.  The clinical investigator as an endangered species.

Authors:  J B Wyngaarden
Journal:  N Engl J Med       Date:  1979-12-06       Impact factor: 91.245

7.  Accelerated approval and breakthrough therapy designation: oncology drug development on speed?

Authors:  James C Yao; Funda Meric-Bernstam; J Jack Lee; S Gail Eckhardt
Journal:  Clin Cancer Res       Date:  2013-07-05       Impact factor: 12.531

Review 8.  Critical issues in response evaluation on computed tomography: lessons from the gastrointestinal stromal tumor model.

Authors:  Haesun Choi
Journal:  Curr Oncol Rep       Date:  2005-07       Impact factor: 5.075

9.  New physician-investigators receiving National Institutes of Health research project grants: a historical perspective on the "endangered species".

Authors:  Howard B Dickler; Di Fang; Stephen J Heinig; Elizabeth Johnson; David Korn
Journal:  JAMA       Date:  2007-06-13       Impact factor: 56.272

10.  Outcome evaluation of the National Cancer Institute career development awards program.

Authors:  Julie L Mason; Ming Lei; Jessica M Faupel-Badger; Erika P Ginsburg; Yvette R Seger; Leo Dijoseph; Joshua D Schnell; Jonathan S Wiest
Journal:  J Cancer Educ       Date:  2013-03       Impact factor: 2.037

View more
  1 in total

1.  Building Capacity for Cancer Research in the Era of COVID-19: Implementation and Results From an International Virtual Clinical Research Training Program in Zambia.

Authors:  Kevin Diao; Dorothy C Lombe; Catherine K Mwaba; Juliana Wu; Darya A Kizub; Carrie A Cameron; Elizabeth Y Chiao; Susan C Msadabwe; Lilie L Lin
Journal:  JCO Glob Oncol       Date:  2022-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.